Johannes Jacob Pieter Kastelein, Chief Scientific Officer: NewAmsterdam Pharma NAMS Sell · Filed 03/09

Trade details

Type: Insider sale
Amount: $3,071,678.61
Shares · price: 101,409 sh · $30.29 a share
Held after: 69,302 sh
Stock: NewAmsterdam Pharma NAMS
Person: Johannes Jacob Pieter KasteleinChief Scientific Officer
Trade date: 26/03/09
Filed: 26/03/09
Days to filing: 0 days

Sold 59.4% of holdings

Share of holding sold: 59.4%

NewAmsterdam Pharma trades, last 26 weeks

What else happened in NewAmsterdam Pharma around then

Filed or reported within 30 days of the trade day · 02/07~04/08

Johannes Jacob Pieter Kastelein's recent trades

Johannes Jacob Pieter KasteleinChief Scientific Officer
Planned sale10b5-1 planNewAmsterdam Pharma
Planned sale10b5-1 plan
NewAmsterdam Pharma
NAMS
$3.5M
125,000 sh
$3.5M
Filed 08/24
Traded 08/24
Johannes Jacob Pieter KasteleinChief Scientific Officer
Sell10b5-1 planNewAmsterdam Pharma
Sell10b5-1 plan
NewAmsterdam Pharma
NAMS
$3.2M
104,467 sh
$3.2M
Filed 03/09
Traded 03/05
Johannes Jacob Pieter KasteleinChief Scientific Officer
Sell10b5-1 planNewAmsterdam Pharma
Sell10b5-1 plan
NewAmsterdam Pharma
NAMS
$2.9M
94,124 sh
$2.9M
Filed 03/09
Traded 03/06
Johannes Jacob Pieter KasteleinChief Scientific Officer
Planned sale10b5-1 planNewAmsterdam Pharma
Planned sale10b5-1 plan
NewAmsterdam Pharma
NAMS
$9.4M
300,000 sh
$9.4M
Filed 03/05
Traded 03/02
Johannes Jacob Pieter KasteleinChief Scientific Officer
SellNewAmsterdam Pharma
Sell
NewAmsterdam Pharma
NAMS
$1.1M
30,789 sh
$1.1M
Filed 02/24
Traded 02/20

Johannes Jacob Pieter Kastelein, Chief Officer — sold $3.1M of NewAmsterdam Pharma NAMS · 59.4% of holdings · 10b5-1 plan | Whalegun